Quidel

Yahoo Finance • 21 hours ago

QuidelOrtho Corp. (QDEL) Traded Lower Due to Macro Concerns

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market showcased a significant recovery during the qua... Full story

Yahoo Finance • 2 days ago

Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters

SAN DIEGO, Sept. 25, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released the latest episode of its Science Bytes podcast, featuring Dr. Terry O'Neil, President and Medical Dire... Full story

Yahoo Finance • 23 days ago

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In QuidelOrtho (QDEL) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in QuidelOrtho between Februa... Full story

Yahoo Finance • last month

QuidelOrtho names Erich Wolff as EVP of strategy & corporate development

SAN DIEGO - QuidelOrtho Corporation (NASDAQ:QDEL), a provider of in vitro diagnostics, has appointed Erich Wolff as Executive Vice President, Strategy & Corporate Development, the company announced Tuesday. In his new role, Wolff will rep... Full story

Yahoo Finance • 2 months ago

Quidel stock price target lowered to $55 by Raymond James on prudent guidance

Investing.com - Raymond James has lowered its price target on Quidel Corp . (NASDAQ:QDEL) to $55.00 from $60.00 while maintaining an Outperform rating on the stock. The new target represents significant upside potential from the current p... Full story

Yahoo Finance • 2 months ago

QuidelOrtho narrows China outlook to mid-single-digit growth as cost actions drive margin gains

Earnings Call Insights: QuidelOrtho Corporation (QDEL) Q2 2025 MANAGEMENT VIEW * CEO Brian J. Blaser reported that "total revenue of $614 million grew 1%, excluding COVID and the Donor Screening business, which we are in the process of... Full story

Yahoo Finance • 2 months ago

QuidelOrtho Reports Second Quarter 2025 Financial Results

― Labs revenue grew 4% as reported and 5% in constant currency ― ― Adjusted EBITDA margin improved by 330 basis points; Achieved $100 million annualized cost savings from initiatives announced in 2024 ― ― Company reiterates full-year 2025... Full story

Yahoo Finance • 2 months ago

QuidelOrtho Corporation (QDEL): A Bull Case Theory

We came across a bullish thesis on QuidelOrtho Corporation on Valueinvestorsclub.com by Novana. In this article, we will summarize the bulls’ thesis on QDEL. QuidelOrtho Corporation's share was trading at $27.39 as of July 25th. QDEL’s tra... Full story

Yahoo Finance • 2 months ago

Quidel stock hits 52-week low at $23.75

Quidel (NASDAQ:QDEL) Corporation’s stock reached a 52-week low, closing at $23.75, with a market capitalization of $1.6 billion. This marks a significant downturn for the company, which has experienced a 42.83% decrease in its stock value... Full story

Yahoo Finance • 2 months ago

PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending shockwaves across the health... Full story

Yahoo Finance • 3 months ago

Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 3 months ago

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider o... Full story

Yahoo Finance • 4 months ago

QuidelOrtho to discontinue Savanna platform development

[Investor interacting chart analysis problem Debt ceiling prepare for worst case sceniro] primeimages/iStock via Getty Images QuidelOrtho (NASDAQ:QDEL [https://seekingalpha.com/symbol/QDEL]) said on Tuesday that it plans to discontinue it... Full story

Yahoo Finance • 4 months ago

Luxfer, LGI Homes, QuidelOrtho, Dentsply Sirona, and AdaptHealth Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +2.0%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to Ju... Full story

Yahoo Finance • 6 months ago

1 Stock Under $50 with Exciting Potential and 2 to Brush Off

1 Stock Under $50 with Exciting Potential and 2 to Brush Off Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should r... Full story

Yahoo Finance • 12 months ago

QuidelOrtho Insider Ups Holding By 54% During Year

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider tra... Full story

Yahoo Finance • last year

QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference

SAN DIEGO, May 23, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and tran... Full story

Yahoo Finance • 2 years ago

14 Best Beaten Down Stocks To Buy Right Now

In this piece, we will take a look at the 14 best beaten down stocks to buy right now. If you want to skip our coverage of the latest events in the stock market, then you can take a look at the 5 Best Beaten Down Stocks To Buy Right Now.... Full story

Yahoo Finance • 2 years ago

QuidelOrtho Corp (QDEL) Reports Mixed Results Amidst Respiratory Revenue Decline

Revenue: QuidelOrtho Corp (NASDAQ:QDEL) reported a decrease in total revenue to $743 million in Q4 2023, down from $867 million in the prior year period. Net Income: GAAP net income for Q4 2023 was $7 million, with diluted earnings per sha... Full story

Yahoo Finance • 2 years ago

QuidelOrtho to Participate in the Evercore ISI Conference

SAN DIEGO, November 16, 2023--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion med... Full story